Ligand Pharmaceuticals Inc (NASDAQ:LGND)

67.55
Delayed Data
As of Mar 04
 +1.10 / +1.66%
Today’s Change
41.99
Today|||52-Week Range
80.21
+26.95%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues30.0M31.4M49.0M64.5M
 
 
 
 
 
Cost of Goods Sold2.1M874.0K3.1M9.1M
 
 
 
 
 
Depreciation And Amortization2.8M2.7M2.7M--
 
 
 
 
 
Operating ExpensesGross Income25.1M27.8M43.2M55.4M
 
 
 
 
 
General Expenses25.3M26.9M27.3M34.7M
 
 
 
 
 
Research And Development10.3M10.8M9.3M12.1M
 
 
 
 
 
Total Operating Expenses30.2M30.5M33.0M43.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-140.0K889.0K16.0M20.7M
 
 
 
 
 
Extraordinary Credit22.0K0.000.00--
 
 
Extraordinary Charge-2.7M-2.0M-4.6M-6.2M
 
 
 
 
 
Interest Expense On Debt2.5M3.3M2.1M--
 
 
 
 
Other Expenses2.3M516.0K-63.0K-3.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.0M-3.9M9.2M--
 
 
 
 
Income Taxes-13.1M-1.2M-374.0K-410.0K
 
 
 
 
 
Minority Interest0.000.000.00-1.1M
 
 
Extraordinary Items3.0K2.1M2.6M--
 
 
 
 
Net Income10.2M-2.7M8.8M12.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS--19.9M20.3M20.4M
 
 
 
 
Shares To Calculate EPS Diluted--19.9M20.7M21.4M
 
 
 
 
 
Earnings Per ShareEPS$0.52-$0.03$0.55$0.56
 
 
 
 
 
EPS Diluted---$0.13$0.43$0.56
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account